CalciMedica is trading at $1.77 (+6.63%) in pre-market; the reason for the move remains unclear.

  • No clear company-specific catalyst was found for the October 29 move. The press-release page lists no October 28–29 announcement; its latest listed release is dated September 8.
  • Broader markets were mixed, and available evidence does not establish a market-wide explanation for the gain.